Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
Ehlermann P, Eggers K, Bierhaus A, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, Remppis A.
Cardiovasc Diabetol. 2006 Mar 30;5:6.
Related citations
RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K, Sikora K, Lorenz M, Taubert T, Moobed M, Baumann G, Stangl K, Stangl V.
Exp Clin Endocrinol Diabetes. 2011 Jun;119(6):353-7. Epub 2011 Apr 6.
S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells.
Eue I, König S, Pior J, Sorg C.
Int Immunol. 2002 Mar;14(3):287-97.
Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
Chen YS, Yan W, Geczy CL, Brown MA, Thomas R.
Arthritis Res Ther. 2009;11(2):R39. Epub 2009 Mar 11.
Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion.
Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA.
J Immunol. 2003 Mar 15;170(6):3233-42.
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RS, Geczy CL.
J Biol Chem. 2005 Dec 16;280(50):41521-9. Epub 2005 Oct 10.
Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D.
Clin Cancer Res. 2005 Jul 15;11(14):5146-52.
The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis.
Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, Yamamoto H, Chazin WJ, Nakatani Y, Yui S, Makino H.
Arthritis Res Ther. 2006;8(3):R69. Epub 2006 Apr 13.
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R.
Circulation. 2002 Feb 19;105(7):816-22.
Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide.
Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA.
J Immunol. 2003 Sep 1;171(5):2602-9.
Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway.
Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D, Zhang X.
Antioxid Redox Signal. 2008 Oct;10(10):1699-712.
Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
Valencia JV, Mone M, Koehne C, Rediske J, Hughes TE.
Diabetologia. 2004 May;47(5):844-52. Epub 2004 May 1.
[Possibility of formation of the S100A8/A9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles].
Ishihara K, Namura T, Murayama H, Arai S, Totani M, Ikemoto M.
Rinsho Byori. 2009 Apr;57(4):324-31. Japanese.
Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW, Nedjadi T, Sheikh AA, Tweedle EM, Tonack S, Honap S, Jenkins RE, Park BK, Schwarte-Waldhoff I, Khattak I, Azadeh B, Dodson A, Kalirai H, Neoptolemos JP, Rooney PS, Costello E.
Carcinogenesis. 2010 Sep;31(9):1541-51. Epub 2010 Jul 9.
AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.
Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, Danze PM, Dequiedt P.
Kidney Int. 2002 Jan;61(1):148-56.
S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.
Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M.
J Leukoc Biol. 2008 Jun;83(6):1484-92. Epub 2008 Mar 13.
Nicotine enhances human vascular endothelial cell expression of ICAM-1 and VCAM-1 via protein kinase C, p38 mitogen-activated protein kinase, NF-kappaB, and AP-1.
Ueno H, Pradhan S, Schlessel D, Hirasawa H, Sumpio BE.
Cardiovasc Toxicol. 2006;6(1):39-50.
Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators-activated receptor gamma.
Ma L, Gao HQ, Li BY, Ma YB, You BA, Zhang FL.
J Cardiovasc Pharmacol. 2007 May;49(5):293-8.
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.
Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, Varki N, Kronenberg M, Freeze HH, Srikrishna G.
Carcinogenesis. 2008 Oct;29(10):2035-43. Epub 2008 Aug 9.
S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.
Boyd JH, Kan B, Roberts H, Wang Y, Walley KR.
Circ Res. 2008 May 23;102(10):1239-46. Epub 2008 Apr 10.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on